Internal Medicine Alert - November 30, 2006

Target Audience:

This activity is intended for the internist and family practitioner.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Editor
Stephen Brunton, MD
Clinical Professor
University of California, Irvine

Peer Reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY

Associate Editors
Eileen C. West, MD
Director
Primary Care Women's Health
Clinical Assistant Professor
Internal Medicine
Obstetrics and Gynecology;
University of Oklahoma Health Sciences Center,
Oklahoma City

Mary Elina Ferris, MD
Clinical Associate Professor
University of Southern California

James Chan, PhD, PharmD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

William T. Elliott, MD, FACP
Chair
Formulary Committee
Northern California Kaiser Permanente;
Asst. Clinical Professor of Medicine
University of California
San Francisco

Louis Kuritzky, MD
Clinical Assistant Professor
University of Florida
Gainesville

Authors
Joseph F. John, Jr., MD, FACP, FIDSA, FSHEA
Associate Chief of Staff for Education
Ralph H. Johnson Veterans Administration Medical Center;
Professor of Medicine
Medical University of South Carolina
Charleston

Michael H. Crawford, MD
Professor of Medicine
Chief of Clinical Cardiology
University of California
San Francisco

Stan Deresinski, MD, FACP
Clinical Professor of Medicine
Stanford
Associate Chief of Infectious Diseases
Santa Clara Valley Medical Center

Subjects:

  • Psoriasis: A Risk Factor for MI?
  • Meal Size More Important Than Calorie Content
  • Deep Dive: How Nose Picking Affects Nasal Carriage of Staph
  • Importance of HDL Cholesterol in ACS
  • Traveler's Diarrhea and Irritable Bowel Syndrome
  • Sitagliptin Phosphate Tablets (Januvia™)
  • Clinical Briefs By Louis Kuritzky, MD

Objectives:

  • Describe new findings in differential diagnosis and treatment of various diseases
  • Describe controversies, advantages, and disadvantages of those advances
  • Describe cost-effective treatment regimens
  • Describe the pros and cons of new screening procedures.

Financial Disclosure:

Internal Medicine Alert's editor, Stephen Brunton, MD, is a consultant for Sanofi-Aventis, Ortho-McNeil, McNeil, Abbott, Novo Nordisk, Eli Lilly, Endo, EXACT Sciences, and Astra-Zeneca, and serves on the speaker's bureau of McNeil, Sanofi-Aventis, and Ortho-McNeil. Peer reviewer Gerald Roberts, MD, associate editors Eileen C. West, MD, Mary Elina Ferris, MD, James Chan, PharmD, PhD, and William T. Elliott, MD, FACP report no financial relationship to this field of study. Author Joseph F. John, Jr., MD, FACP, FIDSA, FSHEA does research for Merck, is a consultant for Cubist, Roche, and bioMerieux, and is on the speaker’s bureau for Pharmacia, GSK, Merck, Bayer, and Wyeth. Author Michael H. Crawford, MD is on the speaker's bureau for Pfizer. Author Stan Deresinski, MD, FACP serves on the speaker’s bureau of Merck, Pharmacia, GlaxoSmithKline, Pfizer, Bayer, and Wyeth, and does research for Merck. Associate editor Louis Kuritzky, MD is a consultant for GlaxoSmithKline and is on the speaker’s bureau of GlaxoSmithKline, 3M, Wyeth-Ayerst, Pfizer, Novartis, Bristol-Myers Squibb, AstraZeneca, Jones Pharma, and Boehringer Ingelheim.

Copyright 2006 AHC Media. All rights reserved.